Voyageur Pharmaceuticals Ltd.
VYYRF
$0.08
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.42M | -2.53M | -2.24M | -1.55M | -1.58M |
| Total Depreciation and Amortization | 800.00 | 800.00 | 900.00 | 1.00K | 1.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 318.00K | 574.50K | 645.00K | 525.10K | 502.60K |
| Change in Net Operating Assets | 884.50K | 141.40K | 71.30K | 173.40K | 267.90K |
| Cash from Operations | -1.22M | -1.81M | -1.53M | -853.30K | -806.80K |
| Capital Expenditure | -183.60K | -194.00K | -153.80K | -110.10K | -123.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -183.60K | -194.00K | -153.80K | -110.10K | -123.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.73M | 3.35M | 3.33M | 1.71M | 1.62M |
| Repurchase of Common Stock | -- | -- | -- | -- | -5.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -365.10K | -431.20K | -37.30K | 31.40K | 97.30K |
| Cash from Financing | 1.00M | 2.08M | 2.36M | 1.22M | 1.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -398.20K | 72.90K | 675.30K | 256.20K | 267.90K |